In the article "Risks and benefits of clopidogrel–aspirin in minor stroke or TIA: Time course analysis of CHANCE” by Y. Pan et al.,1 there are errors in table 1 for “Moderate to severe bleeding” events in both the ASA and CLP + ASA treatment groups. The corrected table 1 is posted below with changes in bold type. Accordingly, the passage on page 1908 should read “A total of 6 moderate to severe bleedings occurred within the first month in the clopidogrel-aspirin group with 3 during the first week… Only 2 moderate to severe bleedings occurred during the first week of the first month in the aspirin alone group” rather than “A total of 4 moderate to severe bleedings occurred within the first month in the clopidogrel-aspirin group with 1 during the first week… No moderate to severe bleeding occuring within the first month in the aspirin alone group” as originally published. The authors regret the errors.
Time course distribution of ischemic stroke and bleeding by treatment assignment
- © 2019 American Academy of Neurology
Reference
- 1.↵
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.